Novotek launches UK and Ireland brand after acquisition of Kerrco Automation

Novotek UK and Ireland opens following Kerrco Automation acquisition

European industrial IT and automation expert Novotek has launched its UK and Ireland brand following the acquisition of Glasgow-based Kerrco Automation. The rebranded Novotek UK and Ireland will help businesses across the manufacturing, utilities, process and energy sectors to improve all aspects of operational effectiveness. The company aims to deliver this through smart use of both existing and new technologies to connect, analyze and visualize operation data.

Tobias Antius - CEO Novotek group

Novotek UK and Ireland will fulfill the growing demand for digitalization and interconnectivity in the UK market. The company is the UK and Ireland channel partner for GE Digital and GE Automation and Controls, allowing Novotek to supply UK businesses with fourth generation HMI and SCADA systems, such as the iFix HMI software, as well as the Predix industrial internet of things (IIoT) platform.

In addition to its GE offerings, Kerrco Automation’s rebranding as Novotek UK and Ireland gives it access to a selection of new digital products and systems through the Novotek Group.

The full portfolio of Novotek includes the Kepware suite of connectivity and Auvesy’s market leading versioning product for automation equipment as well as Novotek’s specially designed components for iFix and Historian by GE Digital. These components packages provide additional functionality to the standard products, allowing plant and facilities managers to improve the effectiveness of their systems.

“There has been a transformation in the UK IoT market in the past twelve months,” explains George Walker, managing director of Novotek UK and Ireland. “More sectors are now identifying the value to be found in the convergence of IT and operational technology (OT). It’s no longer a predominately industrial movement; we’re seeing a growing interest in the digitalization of critical infrastructure and utilities, such as energy and water, with automation technologies.

“As part of the Novotek Group, we can apply the company’s insight into similar projects across Europe to better meet the needs of the UK market. Novotek has a history of providing creative solutions to customer requests in other regions, with the company often guiding customers out of their typical comfort zone to think differently and achieve more. By bringing this approach to the region, we can help businesses across the UK and Ireland to realize their full potential with modern, digital technologies.”

According to a recent global IoT survey, roughly one third of businesses will be looking to invest between $100,000 and $1 million over the next five years. However, Novotek argues that the amount that businesses are willing to invest in IoT is not necessarily as important as how the technology is implemented and how adoption is handled.

“The key to successfully adopting digitalization is expertise and experience,” says Tobias Antius, CEO of Novotek. “Kerrco Automation and Novotek both had the technical capabilities, product portfolio and industry experience to provide this expertise. This brought the two companies together and, by pooling our resources, we are able to help more UK businesses lead from the front of the IoT market, as well as better serve our existing customers in the region.”

The Novotek Group, which is headquartered in Sweden and listed on the Nasdaq Stockholm, has experienced significant growth in the UK and Irish markets in recent months. This is due in part to the region’s growing interest in digitalization, driven by the UK’s Made Smarter review and a wider industry awareness of the IIoT.

As part of its launch, Novotek UK and Ireland is calling for plant and utilities managers and engineers to experience the value and viability of modernizing their automation systems and digitalizing operations.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
FDA-approved surgical robots trend toward autonomy, study finds